Show simple item record

Metabolic Syndrome and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Study

dc.contributor.authorYaffe, Kristineen_US
dc.contributor.authorHaan, Mary N.en_US
dc.contributor.authorBlackwell, Terrien_US
dc.contributor.authorCherkasova, Elenaen_US
dc.contributor.authorWhitmer, Rachel A.en_US
dc.contributor.authorWest, Nancyen_US
dc.date.accessioned2010-04-01T15:07:59Z
dc.date.available2010-04-01T15:07:59Z
dc.date.issued2007-05en_US
dc.identifier.citationYaffe, Kristine; Haan, Mary; Blackwell, Terri; Cherkasova, Elena; Whitmer, Rachel A.; West, Nancy (2007). "Metabolic Syndrome and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Study." Journal of the American Geriatrics Society 55(5): 758-762. <http://hdl.handle.net/2027.42/65598>en_US
dc.identifier.issn0002-8614en_US
dc.identifier.issn1532-5415en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65598
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17493197&dopt=citationen_US
dc.description.abstractTo investigate the effect of metabolic syndrome on cognitive function in an elderly Latino population and to determine whether inflammation modifies this association. DESIGN : A longitudinal cohort study. SETTING : Sacramento area and the surrounding California counties from 1998 to 1999. PARTICIPANTS : One thousand six hundred twenty-four Latinos aged 60 and older who participated in the Sacramento Area Latino Study of Aging. MEASUREMENTS : Baseline metabolic syndrome was calculated using the Third Adult Treatment Panel of the National Cholesterol Education Program. Cognitive function was measured using the Modified Mini-Mental State Examination (3MS) and the Delayed Word-List Recall (DelRec), a verbal memory test. The effect of metabolic syndrome on cognitive change scores was examined using random effects models; in addition, the effect of the individual components of the syndrome on cognitive change was examined. RESULTS : Of the 1,624 participants, 718 (44%) had metabolic syndrome at baseline. Those with metabolic syndrome had worse 3-year change scores on 3MS ( P =.04) and DelRec ( P =.03). Multivariate adjustment attenuated the results for DelRec but not for 3MS. This association was especially pronounced in participants with a high serum level of inflammation, resulting in an average 3MS score 0.64 points lower per year ( P =.03) for those with metabolic syndrome. Individual components of metabolic syndrome were not associated with cognitive decline except for elevated glucose on the DelRec ( P =.02) and high blood pressure on 3MS ( P =.05). CONCLUSION : Metabolic syndrome and inflammation may both contribute to cognitive decline in older people of diverse backgrounds. The results also suggest that, in elderly Latinos, the composite measure of metabolic syndrome is a greater risk for cognitive decline than its individual components.en_US
dc.format.extent464834 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2007, by the American Geriatrics Societyen_US
dc.subject.otherMetabolic Syndromeen_US
dc.subject.otherCognitionen_US
dc.subject.otherDementiaen_US
dc.subject.otherDiabetes Mellitusen_US
dc.subject.otherElderlyen_US
dc.titleMetabolic Syndrome and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Studyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumSchool of Public Health, University of Michigan, Ann Arbor, Michigan ;en_US
dc.contributor.affiliationotherPsychiatry ,en_US
dc.contributor.affiliationotherNeurology ,en_US
dc.contributor.affiliationotherEpidemiology and Biostatistics , anden_US
dc.contributor.affiliationotherGeriatrics, University of California at San Francisco, San Francisco, California ;en_US
dc.contributor.affiliationotherSan Francisco VA Medical Center, San Francisco, California ;en_US
dc.contributor.affiliationotherCalifornia Pacific Medical Center, San Francisco, California ; anden_US
dc.contributor.affiliationotherDivision of Research, Kaiser Permanente, Oakland, California.en_US
dc.identifier.pmid17493197en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65598/1/j.1532-5415.2007.01139.x.pdf
dc.identifier.doi10.1111/j.1532-5415.2007.01139.xen_US
dc.identifier.sourceJournal of the American Geriatrics Societyen_US
dc.identifier.citedreference1.  Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 ; 285 : 2486 – 2497.en_US
dc.identifier.citedreferenceYaffe K, Kanaya A, Lindquist K et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004 ; 292 : 2237 – 2242.en_US
dc.identifier.citedreference3.  U.S. Census Bureau. National Population Projections. Washington, DC : U.S. Government Printing Office, 2000.en_US
dc.identifier.citedreferenceHaan MN, Mungas DM, Gonzalez HM et al. Prevalence of dementia in older Latinos : The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 2003 ; 51 : 169 – 177.en_US
dc.identifier.citedreferenceTeng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987 ; 48 : 314 – 318.en_US
dc.identifier.citedreferenceGonzalez HM, Mungas D, Reed BR et al. A new verbal learning and memory test for English- and Spanish-speaking older people. J Int Neuropsychol Soc 2001 ; 7 : 544 – 555.en_US
dc.identifier.citedreferenceRadloff L. The CES-D Scale : A self-report depression scale for research in the general population. Appl Psychol Meas 1977 ; 1 : 385 – 401.en_US
dc.identifier.citedreferenceCuellar I, Arnold B, Maldonado R. Acculturation Rating Scale for Mexican Americans. II. A revision of the original ARSMA Scale. Hisp J Behav Sci 1995 ; 17 : 274 – 304.en_US
dc.identifier.citedreferenceLaird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982 ; 38 : 963 – 974.en_US
dc.identifier.citedreferenceLauner LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995 ; 274 : 1846 – 1851.en_US
dc.identifier.citedreferenceKnopman D, Boland LL, Mosley T et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001 ; 56 : 42 – 48.en_US
dc.identifier.citedreferenceMoroney JT, Tang MX, Berglund L et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999 ; 282 : 254 – 260.en_US
dc.identifier.citedreferenceEvans RM, Emsley CL, Gao S et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease : A population-based study of African Americans. Neurology 2000 ; 54 : 240 – 242.en_US
dc.identifier.citedreferenceWu JH, Haan MN, Liang J et al. Impact of diabetes on cognitive function among older Latinos : A population-based cohort study. J Clin Epidemiol 2003 ; 56 : 686 – 693.en_US
dc.identifier.citedreferenceYaffe K, Blackwell T, Kanaya AM et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004 ; 63 : 658 – 663.en_US
dc.identifier.citedreferenceGrodstein F, Chen J, Wilson RS et al. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001 ; 24 : 1060 – 1065.en_US
dc.identifier.citedreferenceBarzilay JI, Abraham L, Heckbert SR et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. The Cardiovascular Health Study. Diabetes 2001 ; 50 : 2384 – 2389.en_US
dc.identifier.citedreferencePradhan AD, Manson JE, Rifai N et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 ; 286 : 327 – 334.en_US
dc.identifier.citedreferenceYaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003 ; 61 : 76 – 80.en_US
dc.identifier.citedreferenceMcGeer EG, McGeer PL. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 1999 ; 5 : 821 – 836.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.